Skye Bioscience, Inc. (NASDAQ:SKYE) Given Consensus Rating of “Buy” by Analysts
Skye Bioscience, Inc. (NASDAQ:SKYE – Get Free Report) has been assigned an average rating of “Buy” from the six ratings firms that are presently covering the firm, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a buy rating. The average 12 month price target among brokerages that have updated their coverage […]
Skye Bioscience, Inc. (NASDAQ:SKYE – Get Free Report) has been assigned an average rating of “Buy” from the six ratings firms that are presently covering the firm, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a buy rating. The average 12 month price target among brokerages that have updated their coverage […]